VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026)
Powered by 
Analysis
VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 10.41% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 8.63% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 10.17% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 5.98% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 17.37% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 7.04% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 17.95% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | -1.41% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 18.05% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | -71.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -192.61% |
| Jan 31, 2026 | 57.43% |
| Oct 31, 2025 | 236.57% |
| Jul 31, 2025 | -158.14% |
| Apr 30, 2025 | 248.63% |
| Jan 31, 2025 | 130.27% |
| Oct 31, 2024 | 59.89% |
| Jul 31, 2024 | -63.00% |
| Apr 30, 2024 | 123.09% |
| Jan 31, 2024 | 59.42% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -29.18% |
| Apr 30, 2023 | 44.99% |
| Jan 31, 2023 | -55.05% |
| Oct 31, 2022 | 28.73% |
| Jul 31, 2022 | 28.21% |
| Apr 30, 2022 | -25.39% |
| Jan 31, 2022 | 30.90% |
| Oct 31, 2021 | -54.96% |
| Jul 31, 2021 | 12.82% |